〔Day Digest〕Soft September Nonfarm Knocks October Fed Hike Off the Table — December Base Case Holds at Huatai and JPMorgan, AI Bond Slump Caps September at $23B, A-share ERP Re-reads Through FX Swaps

0. Daily Arc

Front-end Fed easing got reinforcement from a soft September nonfarm: Huatai Securities knocks October consecutive hikes off the table and keeps December as the base case ^[1], and JPMorgan concurs on low October probability "unless…" ^[2]. The long end refuses to play along — the US Treasury curve has pushed higher and market pricing is now more hawkish than the dot plot ^[3]. A-share drawdown has not matched the Treasury move because FX swap points compressed in parallel ^[3]. In credit, Morgan Stanley frames the $23B September AI bond print as a "pause, not retreat" ahead of a Q4 restart that will not match June's $113B peak ^[4]. Equity strategists argue a worst-case is already in price and the Q3-report window is the next catalyst ^[5].

1. Fed Policy: October Off, December On

• **[NEW] Huatai Securities**: September nonfarm missed expectations; the 3-month average sits at 51k near balanced employment, with the unemployment rate still low — a "robust but not tight" labor market ^[1]. Wage growth and real income slowed, leaving consumer spending unlikely to extend August's strength ^[1]. Leading indicator NFIB hiring willingness points to a still-weak October print with a possible rebound thereafter; base case is no October hike, another 25bp in December ^[1].
• **[NEW] JPMorgan**: Post-nonfarm, October Fed hike probability is "low, unless…" — the ellipsis signals conditional language rather than a flat denial ^[2]. *(Single source, headline-only relay — treat as unverified ^[2].)*
• **[NEW] (single source / unverified)**: Cato Institute op-ed titled "Make the Fed's Report to Congress Worth Reading" ^[6] — no body text in the packet, content unknown.

2. A-share Valuation: ERP Re-read Through FX Swaps

• **[NEW] Sina Finance strategy note (broker research index)**: US Treasury yields have risen sharply, equity risk premium has dropped, and market pricing is now more hawkish than the dot plot ^[3]. Anchoring on US Treasury yields alone makes A-share look "not cheap"; anchoring on China bond yields alone makes it "relatively cheap" — a self-contradiction ^[3].
• **[NEW] The FX swap fix**: The contradiction dissolves once FX swap points are netted out — overseas investors' true cost of holding RMB is the US Treasury yield minus the corresponding FX swap, not the Treasury yield alone ^[3]. On this measure, A-share ERP sits near its two-year average, suggesting A-share is "not expensive" even in USD terms ^[3].
• **[NEW] The recent pressure pivot**: Why did A-share hold up while US Treasuries sold off? FX swap points declined and absorbed the move ^[3]. Why is the market now under sustained pressure despite that mechanism? RMB spot has turned to depreciation, breaking the offset ^[3].

3. AI Bond Slump: September Caps at $23B, Q4 Restart Priced In

• **[NEW] Morgan Stanley via Wall Street CN**: September global AI-related bond issuance came in at roughly $23B — the second-lowest month of 2026 ^[4]. US investment-grade AI issuance printed zero ^[4]. YTD total AI bond issuance stands at $466B, more than double 2025's $216B full-year ^[4].
• **[NEW] Hyperscaler concentration**: Six hyperscalers (Google, Amazon, Meta, Microsoft, plus Oracle and SpaceX) have issued ~$254B all-currency YTD, of which ~$132B is US investment-grade from the top four alone, up ~25x year-over-year ^[4]. June's $113B single-month peak will not be repeated, but Q4 is expected to restart ^[4].
• **[NEW] Why September cooled**: Not fundamentals or capital scarcity, but front-loaded prior issuance, data center construction hitting regulatory/political headwinds, and sharp rate moves forcing project-level term renegotiations ^[4]. Non-USD activity continued — Amazon printed a £4.25B four-tranche deal ^[4].

4. Sector Calls and AI Drug Discovery

• **[NEW] Manufacturing October view (Sina Finance broker research index)**: Macro — profit growth slows under high base ^[7]. Electric new energy — continue bullish on household storage, watch new directions ^[7]. Machinery — TGV equipment: 0-to-1 new technology direction, industry development accelerating ^[7]. Auto — liquid cooling, gas turbines and robot orders fulfilling faster, continue bullish on auto AI+ assets ^[7]. Environment — Q3 report window, emphasize certainty ^[7]. Military — bullish on high-prosperity infrared ^[7]. Construction — advanced manufacturing investment promotes steel structure demand repair, watch growth and profit improvement ^[7].
• **[NEW] CITIC Securities on AI drug discovery (AIDD)**: AIDD companies are generally in early stage, industry expected to enter accelerated growth ^[8]. Three business models — pure SAAS, AI+CRO services, and AI-driven innovative drug companies; most firms use a combination ^[8]. Overall market still small, but with more capital participation, technology iteration, and AI pipeline validation, the harvest period may be approaching ^[8].
• **[NEW] Monthly top stock combination review (Sina Finance broker research index)**: September CSI 300 -5.65%, ChiNext -8.73%; top stock combination -4.98%, outperformed CSI 300 by 0.67 ppt and ChiNext by 3.75 ppt ^[5]. September 29 turnover fell back to ~1.4 trillion yuan, with stock-game features obvious ^[5]. October outlook: with the Fed hike landed, domestic heavyweight policy release, and growth sector valuation digested, negative impact on the market will marginally ease, but a new round of incremental catalyst is needed; mid-October opens the Q3-report dense disclosure window ^[5].